These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 6110604

  • 1. Acute effects of alloxan- and streptozotocin-induced insulin deficiency on somatostatin and glucagon secretion by the perfused isolated rat pancreatico-duodenal preparation.
    Goto Y, Berelowitz M, Frohman LA.
    Diabetologia; 1981; 20(1):66-71. PubMed ID: 6110604
    [Abstract] [Full Text] [Related]

  • 2. Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan.
    Grill V, Efendić S.
    Diabetologia; 1983 Jan; 24(1):47-51. PubMed ID: 6131006
    [Abstract] [Full Text] [Related]

  • 3. Effect of theophylline on insulin, glucagon and somatostatin secretion from the isolated rat pancreatico-duodenal preparation.
    Kudo M, Kimura K, Masuda M, Sasaki S, Sawano S, Takebe K.
    Endocrinol Jpn; 1981 Feb; 28(1):9-16. PubMed ID: 6113955
    [Abstract] [Full Text] [Related]

  • 4. Insulin, glucagon, and somatostatin secretion from isolated perfused rat and chicken pancreas-duodenum.
    Honey RN, Schwarz JA, Mathe CJ, Weir GC.
    Am J Physiol; 1980 Feb; 238(2):E150-6. PubMed ID: 6444782
    [Abstract] [Full Text] [Related]

  • 5. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
    Kurose T, Tsuda K, Ishida H, Tsuji K, Okamoto Y, Tsuura Y, Kato S, Usami M, Imura H, Seino Y.
    Diabetologia; 1992 Nov; 35(11):1035-41. PubMed ID: 1361917
    [Abstract] [Full Text] [Related]

  • 6. Modulation by IBMX, fasting and experimental diabetes of glibenclamide-induced islet hormone release from the perfused rat pancreas.
    Ostenson CG, Grill V, Nylén A, Efendić S.
    Diabete Metab; 1983 Mar; 9(1):58-65. PubMed ID: 6189748
    [Abstract] [Full Text] [Related]

  • 7. Effect of ventromedial hypothalamic lesions on the secretion of somatostatin, insulin, and glucagon by the perfused rat pancreas.
    Goto Y, Carpenter RG, Berelowitz M, Frohman LA.
    Metabolism; 1980 Oct; 29(10):986-90. PubMed ID: 6106879
    [Abstract] [Full Text] [Related]

  • 8. Modulation by alloxan of glucagon and insulin secretion in the isolated perfused rat pancreas.
    Goto Y, Seino Y, Taminato T, Inoue Y, Kadowaki S, Mori K, Imura H.
    Endocrinology; 1978 May; 102(5):1496-500. PubMed ID: 369831
    [Abstract] [Full Text] [Related]

  • 9. Difference in calcium dependency of insulin, glucagon and somatostatin secretion in response to glibenclamide in perfused rat pancreas.
    Efendić S, Grill V, Nylén A, Ostensson CG.
    Diabetologia; 1982 Jun; 22(6):475-9. PubMed ID: 6125449
    [Abstract] [Full Text] [Related]

  • 10. Somatostatin, glucagon, and insulin secretion from perfused pancreas of BB rats.
    Ruggere MD, Patel YC.
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E221-7. PubMed ID: 6147095
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
    Johnson DG, Ensinck JW, Koerker D, Palmer J, Goodner CJ.
    Endocrinology; 1975 Feb; 96(2):370-4. PubMed ID: 1089535
    [Abstract] [Full Text] [Related]

  • 12. Glucagon secretion from the perfused pancreas of streptozotocin-treated rats.
    Weir GC, Knowlton SD, Atkins RF, McKennan KX, Martin DB.
    Diabetes; 1976 Apr; 25(4):275-82. PubMed ID: 131725
    [Abstract] [Full Text] [Related]

  • 13. Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect.
    Ostenson CG, Nylén A, Grill V, Gutniak M, Efendić S.
    Diabetologia; 1986 Dec; 29(12):861-7. PubMed ID: 3106122
    [Abstract] [Full Text] [Related]

  • 14. Effect of a non-sulphonylurea hypoglycaemic agent, KAD-1229 on hormone secretion in the isolated perfused pancreas of the rat.
    Kinukawa M, Ohnota H, Ajisawa Y.
    Br J Pharmacol; 1996 Apr; 117(8):1702-6. PubMed ID: 8732279
    [Abstract] [Full Text] [Related]

  • 15. The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas.
    Szecówka J, Sandberg E, Efendić S.
    Diabetologia; 1980 Aug; 19(2):137-42. PubMed ID: 6106616
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of insulin and somatostatin secretion and stimulation of glucagon release by homologous galanin in perfused rat pancreas.
    Miralles P, Peiró E, Dégano P, Silvestre RA, Marco J.
    Diabetes; 1990 Aug; 39(8):996-1001. PubMed ID: 1695589
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gliclazide directly suppresses arginine-induced glucagon secretion.
    Takahashi K, Yamatani K, Hara M, Sasaki H.
    Diabetes Res Clin Pract; 1994 Jul; 24(3):143-51. PubMed ID: 7988345
    [Abstract] [Full Text] [Related]

  • 20. The dual effect of alloxan modulated by 3-O-methylglucose or somatostatin on insulin secretion in the isolated perfused rat pancreas.
    Goto Y, Seino Y, Note S, Imura H.
    Horm Metab Res; 1980 Apr; 12(4):140-3. PubMed ID: 6104626
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.